vs
Alpha Metallurgical Resources, Inc.(AMR)与科迪华(CTVA)财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是Alpha Metallurgical Resources, Inc.的7.5倍($3.9B vs $519.1M)。Alpha Metallurgical Resources, Inc.净利率更高(-3.3% vs -14.1%,领先10.8%)。科迪华同比增速更快(-1.7% vs -15.7%)。科迪华自由现金流更多($4.2B vs $-10.0M)。过去两年科迪华的营收复合增速更高(-6.7% vs -22.4%)
阿尔法冶金资源(前身为康图拉能源)是行业领先的煤炭供应商,在阿巴拉契亚北部和中部拥有地下及露天煤矿综合体,在宾夕法尼亚州、弗吉尼亚州和西弗吉尼亚州坐拥大型煤田,生产用于炼钢的冶金煤和用于发电的动力煤,供应全球下游客户。
科迪华是一家美国农业科技企业,主营种子与作物保护产品,涵盖除草剂、杀虫剂、杀菌剂及生物制剂,业务覆盖全球110个国家,总部位于印第安纳州印第安纳波利斯,旗下大部分种子产品以先锋良种国际品牌销售。
AMR vs CTVA — 直观对比
营收规模更大
CTVA
是对方的7.5倍
$519.1M
营收增速更快
CTVA
高出13.9%
-15.7%
净利率更高
AMR
高出10.8%
-14.1%
自由现金流更多
CTVA
多$4.2B
$-10.0M
两年增速更快
CTVA
近两年复合增速
-22.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $519.1M | $3.9B |
| 净利润 | $-17.3M | $-552.0M |
| 毛利率 | — | 42.4% |
| 营业利润率 | -4.1% | -13.6% |
| 净利率 | -3.3% | -14.1% |
| 营收同比 | -15.7% | -1.7% |
| 净利润同比 | -711.2% | -1246.3% |
| 每股收益(稀释后) | $-1.35 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMR
CTVA
| Q4 25 | $519.1M | $3.9B | ||
| Q3 25 | $525.2M | $2.6B | ||
| Q2 25 | $548.7M | $6.5B | ||
| Q1 25 | $529.7M | $4.4B | ||
| Q4 24 | $615.4M | $4.0B | ||
| Q3 24 | $669.8M | $2.3B | ||
| Q2 24 | $800.1M | $6.1B | ||
| Q1 24 | $861.3M | $4.5B |
净利润
AMR
CTVA
| Q4 25 | $-17.3M | $-552.0M | ||
| Q3 25 | $-5.5M | $-320.0M | ||
| Q2 25 | $-5.0M | $1.3B | ||
| Q1 25 | $-33.9M | $652.0M | ||
| Q4 24 | $-2.1M | $-41.0M | ||
| Q3 24 | $3.8M | $-524.0M | ||
| Q2 24 | $58.9M | $1.1B | ||
| Q1 24 | $127.0M | $419.0M |
毛利率
AMR
CTVA
| Q4 25 | — | 42.4% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 54.6% | ||
| Q1 25 | — | 47.0% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 32.7% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | 43.2% |
营业利润率
AMR
CTVA
| Q4 25 | -4.1% | -13.6% | ||
| Q3 25 | -0.5% | -14.1% | ||
| Q2 25 | 0.5% | 27.9% | ||
| Q1 25 | -7.6% | 17.7% | ||
| Q4 24 | 1.6% | 2.2% | ||
| Q3 24 | 0.8% | -27.2% | ||
| Q2 24 | 8.8% | 21.9% | ||
| Q1 24 | 16.5% | 10.7% |
净利率
AMR
CTVA
| Q4 25 | -3.3% | -14.1% | ||
| Q3 25 | -1.1% | -12.2% | ||
| Q2 25 | -0.9% | 20.4% | ||
| Q1 25 | -6.4% | 14.8% | ||
| Q4 24 | -0.3% | -1.0% | ||
| Q3 24 | 0.6% | -22.5% | ||
| Q2 24 | 7.4% | 17.2% | ||
| Q1 24 | 14.7% | 9.3% |
每股收益(稀释后)
AMR
CTVA
| Q4 25 | $-1.35 | $-0.80 | ||
| Q3 25 | $-0.42 | $-0.47 | ||
| Q2 25 | $-0.38 | $1.92 | ||
| Q1 25 | $-2.60 | $0.95 | ||
| Q4 24 | $-0.09 | $-0.05 | ||
| Q3 24 | $0.29 | $-0.76 | ||
| Q2 24 | $4.49 | $1.51 | ||
| Q1 24 | $9.59 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $415.6M | $4.5B |
| 总债务越低越好 | $9.8M | $1.7B |
| 股东权益账面价值 | $1.5B | $24.1B |
| 总资产 | $2.3B | $42.8B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.07× |
8季度趋势,按日历期对齐
现金及短期投资
AMR
CTVA
| Q4 25 | $415.6M | $4.5B | ||
| Q3 25 | $457.9M | $2.6B | ||
| Q2 25 | $449.0M | $2.1B | ||
| Q1 25 | $448.0M | $2.0B | ||
| Q4 24 | $481.6M | $3.2B | ||
| Q3 24 | $484.6M | $2.5B | ||
| Q2 24 | $336.1M | $2.0B | ||
| Q1 24 | $269.4M | $1.7B |
总债务
AMR
CTVA
| Q4 25 | $9.8M | $1.7B | ||
| Q3 25 | $2.9M | $1.7B | ||
| Q2 25 | $3.1M | $1.7B | ||
| Q1 25 | $2.4M | $1.8B | ||
| Q4 24 | $2.9M | $2.0B | ||
| Q3 24 | $3.6M | $2.0B | ||
| Q2 24 | $5.3M | $2.5B | ||
| Q1 24 | $6.0M | $2.5B |
股东权益
AMR
CTVA
| Q4 25 | $1.5B | $24.1B | ||
| Q3 25 | $1.6B | $25.2B | ||
| Q2 25 | $1.6B | $25.9B | ||
| Q1 25 | $1.6B | $24.3B | ||
| Q4 24 | $1.6B | $23.8B | ||
| Q3 24 | $1.7B | $24.7B | ||
| Q2 24 | $1.6B | $25.2B | ||
| Q1 24 | $1.6B | $24.8B |
总资产
AMR
CTVA
| Q4 25 | $2.3B | $42.8B | ||
| Q3 25 | $2.3B | $42.2B | ||
| Q2 25 | $2.4B | $41.8B | ||
| Q1 25 | $2.4B | $42.1B | ||
| Q4 24 | $2.4B | $40.8B | ||
| Q3 24 | $2.5B | $41.9B | ||
| Q2 24 | $2.5B | $41.5B | ||
| Q1 24 | $2.5B | $43.6B |
负债/权益比
AMR
CTVA
| Q4 25 | 0.01× | 0.07× | ||
| Q3 25 | 0.00× | 0.07× | ||
| Q2 25 | 0.00× | 0.07× | ||
| Q1 25 | 0.00× | 0.07× | ||
| Q4 24 | 0.00× | 0.08× | ||
| Q3 24 | 0.00× | 0.08× | ||
| Q2 24 | 0.00× | 0.10× | ||
| Q1 24 | 0.00× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $19.0M | $4.4B |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $4.2B |
| 自由现金流率自由现金流/营收 | -1.9% | 106.2% |
| 资本支出强度资本支出/营收 | 5.6% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $17.8M | $2.8B |
8季度趋势,按日历期对齐
经营现金流
AMR
CTVA
| Q4 25 | $19.0M | $4.4B | ||
| Q3 25 | $50.5M | $193.0M | ||
| Q2 25 | $53.2M | $947.0M | ||
| Q1 25 | $22.2M | $-2.1B | ||
| Q4 24 | $56.3M | $4.2B | ||
| Q3 24 | $189.5M | $130.0M | ||
| Q2 24 | $138.1M | $451.0M | ||
| Q1 24 | $196.1M | $-2.6B |
自由现金流
AMR
CTVA
| Q4 25 | $-10.0M | $4.2B | ||
| Q3 25 | $25.4M | $36.0M | ||
| Q2 25 | $18.6M | $829.0M | ||
| Q1 25 | $-16.3M | $-2.2B | ||
| Q4 24 | $13.6M | $4.0B | ||
| Q3 24 | $158.0M | $-24.0M | ||
| Q2 24 | $77.0M | $337.0M | ||
| Q1 24 | $132.5M | $-2.8B |
自由现金流率
AMR
CTVA
| Q4 25 | -1.9% | 106.2% | ||
| Q3 25 | 4.8% | 1.4% | ||
| Q2 25 | 3.4% | 12.8% | ||
| Q1 25 | -3.1% | -49.9% | ||
| Q4 24 | 2.2% | 100.4% | ||
| Q3 24 | 23.6% | -1.0% | ||
| Q2 24 | 9.6% | 5.5% | ||
| Q1 24 | 15.4% | -61.4% |
资本支出强度
AMR
CTVA
| Q4 25 | 5.6% | 5.7% | ||
| Q3 25 | 4.8% | 6.0% | ||
| Q2 25 | 6.3% | 1.8% | ||
| Q1 25 | 7.3% | 2.1% | ||
| Q4 24 | 6.9% | 4.6% | ||
| Q3 24 | 4.7% | 6.6% | ||
| Q2 24 | 7.6% | 1.9% | ||
| Q1 24 | 7.4% | 3.3% |
现金转化率
AMR
CTVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | -3.23× | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.81× | — | ||
| Q2 24 | 2.34× | 0.43× | ||
| Q1 24 | 1.54× | -6.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMR
暂无分部数据
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |